Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.540
-0.160 (-3.40%)
Mar 31, 2025, 10:39 AM EDT - Market open
Precision BioSciences Stock Forecast
DTIL's stock price has decreased by -63.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Precision BioSciences stock have an average target of 37.67, with a low estimate of 19 and a high estimate of 60. The average target predicts an increase of 729.74% from the current stock price of 4.54.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Precision BioSciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,221.59% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,221.59% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,221.59% | Feb 19, 2025 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $34 | Hold → Buy | Upgrades | $34 | +648.90% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,221.59% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
20.43M
from 68.70M
Decreased by -70.27%
Revenue Next Year
32.37M
from 20.43M
Increased by 58.46%
EPS This Year
-5.48
from 1.04
EPS Next Year
-3.86
from -5.48
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.9M | 69.8M | 79.5M | ||
| Avg | 20.4M | 32.4M | 33.5M | ||
| Low | 4.9M | 12.3M | 7.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -30.3% | 241.8% | 145.6% | ||
| Avg | -70.3% | 58.5% | 3.5% | ||
| Low | -92.9% | -40.0% | -77.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.10 | 0.06 | -4.59 | |
| Avg | -5.48 | -3.86 | -4.46 | |
| Low | -9.60 | -6.76 | -4.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.